Dr. Giuseppe Di Caro has over 12 years of leading the design and execution of translational research studies in oncology. He is currently Associate Director of Translational Research for Epic Sciences, acting as a scientific subject matter expert for oncology biomarkers in the breast and lung cancer therapeutic area and clinical development lead in liaison with academic KOLs and biopharma partners. Before that, he was a Research Project Leader (RPL) at Pfizer advancing immune-oncology large molecule programs. He led a large cross-functional team from discovery and Lead optimization to candidate selection and development. His academic tenure included a Ph.D. in Experimental Pathology at the University of Milan and a Postdoctoral fellowship at the University of California San Diego, Department of Pharmacology. He led several peer-reviewed scientific articles aimed to improve the classification of tumor heterogeneity in large datasets of cancer patients and demonstrated the role of various tumor-infiltrating immune cells as predictive biomarkers.
Clinical Dx Showcase:
Session Abstract – PMWC 2023 Silicon Valley
The PMWC 2023 Data Applications in Clinical Diagnostics Showcase will provide a 15-minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Nerodegenerative